+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Comparative Study of a Combination of Zidovudine, Didanosine and Double Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine



A Comparative Study of a Combination of Zidovudine, Didanosine and Double Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine



AMERICAN SOCIETY FOR MICROBIOLOGY Author Human retroviruses and related infections : 125




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029590487

Download citation: RISBibTeXText


Related references

Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients. Aids 14(16): 2567-2574, 2000

A phase II open-label, randomized study of the triple combination of Indinavir, zidovudine and didanosine versus Indinavir alone and zidovudine/didanosine in antiretroviral naive patients. INFECTIOUS DISEASES SOCIETY OF AMERICA Author, NATIONAL INSTITUTES OF HEALTH Author, CENTERS FOR DISEASE CONTROL and PREVENTION Author 3rd Conference on retroviruses and opportunistic infections : 90, 1996

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Annals of Internal Medicine 124(12): 1019-1030, 1996

Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography. Journal of Pharmaceutical and Biomedical Analysis 30(4): 955-960, 7 November, 2002

A randomized, double-blinded comparative trial of the effects of zidovudine, didanosine and nevirapine combinations in antiviral naive, AIDS-free, HIV-infected patients with CD4 counts 200-600/MM3. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 22, 1996

Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team. Journal of Acquired Immune Deficiency Syndromes 22(3): 260-266, 1999

Modelling the use of triple combination therapy in five countries Nevirapine, zidovudine, and didanosine. Aids (london). 12(Suppl. 4): S59,., 1998

Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Value in Health 3(3): 186-201, 2000

Retrospective study of zidovudine or didanosine monotherapy or zalcitabine plus zidovudine combination therapy in patients with early AIDS. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD [Author] Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 209, 1994

Population pharmacokinetics of nevirapine, zidovudine and didanosine after combination therapy in HIV-infected patients. Clinical Pharmacology and Therapeutics 63(2): 182, 1998

Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 22(3): 260-266, 1999

Steady state pharmacokinetics of nevirapine, didanosine, zalcitabine, and zidovudine combination therapy in HIV-1 positive patients. Pharmaceutical Research (New York) 12(9 Suppl. ): S101, 1995

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. New England Journal of Medicine 336(19): 1343-1349, 1997

Combination zidovudine and didanosine therapy for patients remaining persistently hiv p24 antigen positive despite zidovudine monotherapy. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b183, 1992

In HIV-infected individuals who desire combination antiviral therapy, zidovudine plus zalcitabine is preferred to zidovudine plus didanosine. Reviews in Medical Virology 4(1): 5-8, 1994